Scinovex
article Open Access

Comparative study of significance of serum matrix metalloproteinase-13 (MMP-13) and carbohydrate antigen 15.3 (CA15.3) as an early tumor marker in female patients with breast cancer

Sangeeta YadavRati MathurSuresh Singh

Abstract

Aim: To determine the usefulness of serum Matrix metalloproteinase-13 (MMP-13) along with Carbohydrate Antigen 15.3 (CA15.3) as an early tumor marker in female patients with breast cancer.Method: The breast cancer patients were recruited from OPD/IPD of Surgery and Oncology department of SMS Hospital, and evaluated serum MMP-13 and CA15.3. Total 180 subjects were included in this study.90 breast cancer Patients were divided according to different stages and 90 control subjects also included.Results: Serum MMP-13 and CA15.3 level raised significantly in breast cancer patients. Further increases with the advanced stage of the breast cancer.Conclusion: Both MMP-13 and CA15.3 can be useful diagnostic tumor marker in breast cancer.

Protease and Inhibitor MechanismsBreast cancerMedicineCA15-3CA 15-3Tumor markerInternal medicineOncologyCancerMatrix metalloproteinaseAntigen
Citations
2
FWCI
0.17
field-weighted impact
References
13
Percentile
43%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Comparative study of significance of serum matrix metalloproteinase-13 (MMP-13) and carbohydrate antigen 15.3 (CA15.3) as an early tumor marker in female patients with breast cancer · Scinovex